© 2002 by Annals of the Rheumatic Diseases
REPORT
Balancing the immune system: Th1 and Th2
1 Division of Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands
2 University Medical Centre Utrecht, "Wilhelmina Childrens Hospital", Department of Paediatric Immunology, Utrecht, Netherlands
3 Center for Pediatric Rheumatology, University of California San Diego, La Jolla, CA, USA
Correspondence to:
Correspondence to:
Dr W van Eden, Division of Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL Utrecht, Netherlands;
w.eden@vet.uu.nl
Keywords: T cells; immunology
Abbreviations: hsp, heat shock protein; TLR, Toll-like receptor
| The first 150 words of the full text of this article appear below. |
CD4+ T cells are subdivided into Th1 and Th2 cells. Their relative presence or activation is thought to have a regulatory effect on immune behaviour. Until recently, the relative suppression of Th1 cells by the relative increase of Th2 activities, was thought to be a main mechanism of keeping or restoring the balance in a diseased immune system. Nowadays, however, a specialised subset of regulatory T cells is held to be responsible for the main effects of securing a balanced immune system. It is possible that heat shock proteins (hsps) are relevant antigens driving such regulation.
Heat shock proteins are known to be immunodominant antigens of bacteria. They are evolutionarily strongly conserved proteins present in all eukaryotic and prokaryotic cellular organisms and are upregulated by several forms of stress. Despite (the paradigm of) self tolerance, hsp-epitopes homologous to endogenous host hsp sequences have been implicated as T cell epitopes to
This article has been cited by other articles:
-
Spinelli Oliveira, E., Hancock, J. T., Hermes-Lima, M., Isola, D. A., Ochs, M., Yu, J., Wilhem Filho, D.
(2007). Implications of dealing with airborne substances and reactive oxygen species: what mammalian lungs, animals, and plants have to say?. Integr. Comp. Biol.
47: 578-591
[Abstract] [Full Text] -
Zhu, Y.-N., Zhao, W.-M., Yang, Y.-F., Liu, Q.-F., Zhou, Y., Tian, J., Ni, J., Fu, Y.-F., Zhong, X.-G., Tang, W., Zhou, R., He, P.-L., Li, X.-Y., Zuo, J.-P.
(2006). Periplocoside E, an Effective Compound from Periploca sepium Bge, Inhibited T Cell Activation in Vitro and in Vivo. J. Pharmacol. Exp. Ther.
316: 662-669
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
